JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB200408

HRP Anti-Glutaminase antibody [EP7212]

5

(2 Reviews)

|

(5 Publications)

Rabbit Recombinant Monoclonal Glutaminase antibody - conjugated to HRP. Suitable for WB and reacts with Human samples. Cited in 5 publications.

View Alternative Names

GLS1, KIAA0838, GLS, K-glutaminase, L-glutamine amidohydrolase

2 Images
Western blot - HRP Anti-Glutaminase antibody [EP7212] (AB200408)
  • WB

Lab

Western blot - HRP Anti-Glutaminase antibody [EP7212] (AB200408)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 3% milk before being incubated with ab200408 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.

All lanes:

Western blot - HRP Anti-Glutaminase antibody [EP7212] (ab200408) at 1/5000 dilution

All lanes:

Kidney (Human) Tissue Lysate - fetal normal tissue at 10 µg

Predicted band size: 73 kDa

Observed band size: 73 kDa

true

Exposure time: 20min

Western blot - HRP Anti-Glutaminase antibody [EP7212] (AB200408)
  • WB

Lab

Western blot - HRP Anti-Glutaminase antibody [EP7212] (AB200408)

ab200408 was shown to recognize Glutaminase in wild-type HAP1 cells as signal was lost at the expected MW in GLS (Glutaminase) knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and GLS (Glutaminase) knockout samples were subjected to SDS-PAGE. ab200408 and ab184095 (Mouse monoclonal [mAbcam 9484] to GAPDH - Loading Control (Alexa Fluor® 680) loading control) were incubated overnight at 4°C at 1/5000 dilution and 1/1000 dilution respectively. The loading control was imaged using the Licor Odyssey CLx prior to blots being developed with ECL technique.

All lanes:

Western blot - HRP Anti-Glutaminase antibody [EP7212] (ab200408) at 1/5000 dilution

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

GLS (Glutaminase) knockout HAP1 whole cell lysate at 20 µg

Predicted band size: 73 kDa

false

Exposure time: 12min

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP7212

Isotype

IgG

Conjugation

HRP

Excitation/Emission
Carrier free

No

Reacts with

Human, Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.1% Proclin 300 Solution Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Glutaminase also known as GLS or GLS1 is an enzyme that catalyzes the conversion of glutamine to glutamate an important step in cellular nitrogen and energy metabolism. This enzyme weighs approximately 65 kDa and is expressed in various tissues particularly in the brain kidney and liver. Glutaminase exists in two isoforms GLS1 and GLS2 with GLS1 being the more studied due to its role in cancer metabolism.
Biological function summary

Glutaminase plays a central role in cellular processes by facilitating the production of glutamate which is an important neurotransmitter in the brain and a precursor for the synthesis of gamma-aminobutyric acid (GABA). It is not part of a larger complex but acts independently in the mitochondrial matrix where it performs the glutaminase reaction. The activity of this enzyme is monitored closely because it affects multiple cellular functions and has implications in many diseases.

Pathways

Glutaminase is instrumental in the glutaminolysis and tricarboxylic acid (TCA) cycles. These pathways are essential for cellular energy production and biosynthesis. GLS1 activity influences other proteins such as alanine transaminase (ALT) and aspartate transaminase (AST) which also play roles in amino acid metabolism and energy production. Glutaminase inhibitors have been explored as potential therapeutic agents by disrupting the glutaminolysis pathway in cancer cells leading to decreased tumor growth.

Glutaminase has a significant link to cancer and neurodegenerative diseases. In cancer GLS1 activity is often upregulated as tumor cells require increased glutamine metabolism for growth and survival making GLS1 inhibitors a target in cancer therapy. Neurodegenerative disorders such as Alzheimer's disease also show altered glutamate levels implicating glutaminase in disease progression. These disorders highlight the enzyme's potential connections with proteins like NMDA receptors in the brain where glutamate acts as a neurotransmitter affecting synaptic activity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the first reaction in the primary pathway for the renal catabolism of glutamine. Plays a role in maintaining acid-base homeostasis. Regulates the levels of the neurotransmitter glutamate, the main excitatory neurotransmitter in the brain (PubMed : 30239721, PubMed : 30575854, PubMed : 30970188).. Isoform 2. Lacks catalytic activity.
See full target information GLS

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Thoracic cancer 14:2187-2197 PubMed37349870

2023

Circ-PDZD8 promotes cell growth and glutamine metabolism in non-small cell lung cancer by enriching LARP1 via sequestering miR-330-5p.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaopeng Zhu,Tianxing Du,Xi Chen,Peng Hu

Nature communications 13:2958 PubMed35618718

2022

The long noncoding RNA ADIPINT regulates human adipocyte metabolism via pyruvate carboxylase.

Applications

Unspecified application

Species

Unspecified reactive species

Alastair G Kerr,Zuoneng Wang,Na Wang,Kelvin H M Kwok,Jutta Jalkanen,Alison Ludzki,Simon Lecoutre,Dominique Langin,Martin O Bergo,Ingrid Dahlman,Carsten Mim,Peter Arner,Hui Gao

The Kaohsiung journal of medical sciences 37:1027-1037 PubMed34405943

2021

Silencing of circ_0000517 suppresses proliferation, glycolysis, and glutamine decomposition of non-small cell lung cancer by modulating miR-330-5p/YY1 signal pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zhong-Xing Bing,Jia-Qi Zhang,Gui-Ge Wang,Yan-Qing Wang,Tian-Ge Wang,Dan-Qing Li

International journal of biological sciences 16:3100-3115 PubMed33162818

2020

NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence the induction of ASCT2.

Applications

Unspecified application

Species

Unspecified reactive species

Mingchao Ding,Xin Bu,Zhehao Li,Haokun Xu,Lin Feng,Junbi Hu,Xinxin Wei,Jiwei Gao,Yanyan Tao,Bolei Cai,Yanpu Liu,Xuan Qu,Liangliang Shen

Diabetes 67:1949-1961 PubMed30002133

2018

Liver Glutamate Dehydrogenase Controls Whole-Body Energy Partitioning Through Amino Acid-Derived Gluconeogenesis and Ammonia Homeostasis.

Applications

Unspecified application

Species

Unspecified reactive species

Melis Karaca,Juliette Martin-Levilain,Mariagrazia Grimaldi,Lingzi Li,Eva Dizin,Yalin Emre,Pierre Maechler
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com